Clinitech Laboratory Ltd. Promoter Acquires Additional Shares Through Open Market Purchases
Clinitech Laboratory Ltd. announced that Promoter Jagdish Umakant Nayak acquired an additional 4,800 equity shares of the company on March 19 and 20, 2026, through open market purchases.As of March 19, 2026, Mr. Nayak, along with persons acting in concert (PACs) including Mrs. Jyoti Jagdish Nayak, Mr. Ashutosh Jagdish Nayak, Ms. Ananya Jagdish Nayak, and Mr. Anant Umakant Nayak, held 14,55,800 shares, representing 63.78% of the company’s total share and voting capital, and 63.78% of the diluted share and voting capital.
Following the acquisitions, the total holding of Mr. Nayak and his PACs increased to 14,60,600 shares, representing 63.99% of the company’s total share and voting capital, and 63.99% of the diluted share and voting capital.
The company’s total equity share capital and voting capital prior to the acquisition was 22,82,400. The total diluted share and voting capital also remained at 22,82,400 after the acquisition.
Mr. Nayak serves as Promoter and Managing Director of Clinitech Laboratory Ltd. and is identified by PAN AAVPN2102P.
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.